Jensen Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,775,507
| Closed | -$339M | – | 86 |
|
|
2023
Q4 | $339M | Sell |
11,775,507
-340,333
| -3% | -$10.3M | 2.57% | 19 |
|
|
2023
Q3 | $402M | Buy |
12,115,840
+353,202
| +3% | +$12.5M | 3.18% | 14 |
|
|
2023
Q2 | $431M | Buy |
11,762,638
+145,243
| +1% | +$5.65M | 3.17% | 14 |
|
|
2023
Q1 | $469M | Buy |
11,617,395
+1,091,421
| +10% | +$47.1M | 3.7% | 12 |
|
|
2022
Q4 | $539M | Buy |
10,525,974
+549,885
| +6% | +$26.4M | 4.22% | 10 |
|
|
2022
Q3 | $437M | Sell |
9,976,089
-64,005
| -0.6% | -$3.11M | 3.8% | 11 |
|
|
2022
Q2 | $526M | Buy |
10,040,094
+332,121
| +3% | +$16.9M | 4.36% | 8 |
|
|
2022
Q1 | $503M | Buy |
9,707,973
+73,574
| +0.8% | +$3.82M | 3.75% | 11 |
|
|
2021
Q4 | $569M | Sell |
9,634,399
-1,029,457
| -10% | -$51M | 4% | 12 |
|
|
2021
Q3 | $459M | Sell |
10,663,856
-727,361
| -6% | -$32.2M | 3.63% | 12 |
|
|
2021
Q2 | $446M | Sell |
11,391,217
-81,970
| -0.7% | -$3.19M | 3.37% | 13 |
|
|
2021
Q1 | $416M | Buy |
11,473,187
+249,576
| +2% | +$8.86M | 3.33% | 14 |
|
|
2020
Q4 | $413M | Sell |
11,223,611
-548,307
| -5% | -$20.1M | 3.42% | 14 |
|
|
2020
Q3 | $410M | Buy |
11,771,918
+803,127
| +7% | +$28.2M | 3.63% | 12 |
|
|
2020
Q2 | $340M | Buy |
10,968,791
+692,565
| +7% | +$23.5M | 3.26% | 13 |
|
|
2020
Q1 | $318M | Buy |
10,276,226
+920,914
| +10% | +$31.4M | 3.56% | 12 |
|
|
2019
Q4 | $348M | Buy |
9,355,312
+542,520
| +6% | +$19.3M | 3.45% | 12 |
|
|
2019
Q3 | $300M | Buy |
8,812,792
+2,051,642
| +30% | +$74.6M | 3.21% | 13 |
|
|
2019
Q2 | $278M | Buy |
6,761,150
+1,335,721
| +25% | +$53M | 3.17% | 14 |
|
|
2019
Q1 | $219M | Buy |
5,425,429
+312,354
| +6% | +$12.5M | 2.6% | 18 |
|
|
2018
Q4 | $212M | Sell |
5,113,075
-2,630
| -0.1% | -$109K | 2.99% | 16 |
|
|
2018
Q3 | $214M | Buy |
5,115,705
+1,911,545
| +60% | +$73.6M | 2.67% | 19 |
|
|
2018
Q2 | $110M | Buy |
+3,204,160
| New | +$109M | 1.48% | 26 |
|
|
2017
Q2 | – | Sell |
-14,370
| Closed | -$466K | – | 95 |
|
|
2017
Q1 | $466K | Hold |
14,370
| – | – | 0.01% | 78 |
|
|
2016
Q4 | $443K | Sell |
14,370
-475
| -3% | -$14.5K | 0.01% | 55 |
|
|
2016
Q3 | $477K | Buy |
14,845
+1,775
| +14% | +$59.4K | 0.01% | 56 |
|
|
2016
Q2 | $437K | Sell |
13,070
-780
| -6% | -$24.9K | 0.01% | 56 |
|
|
2016
Q1 | $389K | Buy |
13,850
+1,170
| +9% | +$33.4K | 0.01% | 97 |
|
|
2015
Q4 | $388K | Sell |
12,680
-1,264
| -9% | -$39.8K | 0.01% | 70 |
|
|
2015
Q3 | $416K | Sell |
13,944
-1,729
| -11% | -$55.4K | 0.01% | 79 |
|
|
2015
Q2 | $499K | Sell |
15,673
-1,465
| -9% | -$47.7K | 0.01% | 61 |
|
|
2015
Q1 | $566K | Sell |
17,138
-959
| -5% | -$30.5K | 0.01% | 44 |
|
|
2014
Q4 | $535K | Sell |
18,097
-21
| -0.1% | -$602 | 0.01% | 64 |
|
|
2014
Q3 | $508K | Buy |
18,118
+1,454
| +9% | +$40.8K | 0.01% | 48 |
|
|
2014
Q2 | $469K | Sell |
16,664
-927
| -5% | -$26.4K | 0.01% | 66 |
|
|
2014
Q1 | $536K | Buy |
17,591
+695
| +4% | +$20.7K | 0.01% | 61 |
|
|
2013
Q4 | $491K | Buy |
16,896
+696
| +4% | +$20.3K | 0.01% | 68 |
|
|
2013
Q3 | $441K | Sell |
16,200
-2,535
| -14% | -$69K | 0.01% | 65 |
|
|
2013
Q2 | $498K | Buy |
+18,735
| New | +$518K | 0.01% | 68 |
|
Other funds holding PFE
Jensen Investment Management's PFE Position: Q1 2024 in Review
Jensen Investment Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 11,775,507 shares — an estimated $339M sold.
Jensen Investment Management first reported a position in PFE in Q2 2013 and held it in 39 quarters. The position peaked at $569M in Q4 2021. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Jensen Investment Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- Jensen Investment Management sold 11,775,507 Pfizer shares in Q1 2024, an estimated $339M.
- Jensen Investment Management first reported a position in Pfizer in Q2 2013 and held it in 39 quarters.
- Jensen Investment Management's Pfizer position peaked at $569M in Q4 2021.
- 2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Jensen Investment Management's 13F filing for Q1 2024, filed 7 May 2024.